Rural Rocks, the Rural Health Network newsletter by the SWOSU College of Pharmac

Brooks, Cindy

Curry, Randy

English

SWOSU Digital Commons (Southwestern Oklahoma State University)

Southwestern Oklahoma State University SWOSU Digital Commons RURAL ROCKS Newsletters 6-2-2016 June 2016 Randy Curry Southwestern Oklahoma State University, randy.curry@swosu.edu Cindy Brooks Southwestern Oklahoma State University, cindy.brooks@swosu.edu Follow this and additional works at: https://dc.swosu.edu/rural_rocks  Part of the Health Information Technology Commons, Medical Education Commons, Pharmaceutical Preparations Commons, and the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Curry, Randy and Brooks, Cindy, "June 2016" (2016). RURAL ROCKS. 3. https://dc.swosu.edu/rural_rocks/3 This Newsletter is brought to you for free and open access by the Newsletters at SWOSU Digital Commons. It has been accepted for inclusion in RURAL ROCKS by an authorized administrator of SWOSU Digital Commons. An ADA compliant document is available upon request. For more information, please contact phillip.fitzsimmons@swosu.edu. The SWOSU College of Pharmacy Rural Health Network,with the Southwestern Pharmacy Foundation Continuing Education Department,will be offering an Oklahoma State Board of Pharmacy-ApprovedImmunization Training Programon Saturday, July 16on SWOSU campus in Weatherford, Oklahoma.Early Registration is due by July 1.Class size is limited,so be sure to register early.Here is the linkto the brochure with more details including the Registration Form:http://www.southwesternpharmacy.com/docs/ProgramBrochure.pdf.For more program information,please contact Immunization Training Program Coordinator,Randy Curry (randy.curry@swosu.edu or 580-774-3760).Note: see attachment on SWOSU College of Pharmacy Panama Medical Mission Trip (check Facebooks for more pictures.)RECALLS Hummingbird Med Devices Inc. Recalls Hummi Micro-Draw Blood Transfer Device Due to Potential for Parts to Disconnecto http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm503689.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery FDA Drug Safety Communication: FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa,Zyprexa Zydis, Zyprexa Relprevv, and Symbyax)o http://www.fda.gov/Drugs/DrugSafety/ucm499441.htm?source=govdelivery&utm_medium=email&utm_source=govdeliveryo http://reference.medscape.com/features/slideshow/guidelines-review/2016/may?src=wnl_drugguide_160509_mscpref&uac=4045DY&impID=1087868&faf=1#page=2 FDA Panel Backs Approval of Sanofi Combination Diabetes Drugo http://www.firstreportnow.com/articles/us-panel-backs-approval-sanofi-combination-diabetes-drug Hummingbird Med Devices Inc. Recalls Hummi Micro-Draw Blood Transfer Device Due to Potential for Parts to Disconnecto http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm503689.htm?source=govdelivery&utm_medium=email&utm_source=govdeliveryHuman Drug Product Recalls Pending Classification http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm310739.htmAuvi-Q (epinephrine injection, USP)Auto-Injector, 0.3 mg (a) 2 prefilledauto injectors + 1 trainer (NDC 0025-5833-02) and (b) 1 prefilled autoinjector + 1 trainer (NDC 0024-5833-00), Rx Only, Manufactured forSanofi-Aventis US, LLC Bridgewater,NJ 08807 A Sanofi CompanyClassIa) 2081278, 2113841, 2113842,2144138, exp 10/2015; 2440675, exp04/2016; 2506456, 2506460,2546946, 2546947, exp 05/2016;2620206, 2620207, 2659534, exp06/2016; 2692111, 2692112, exp07/2016; 2716517, 2719817,2734079, 2734080, 2734081,2778035, 2800128, exp 08/2016;2800130, 2824828, 2824829,2857516, 2867928, 2870928,Defective Delivery System; potential tohave inaccurate dosage deliverySanofi-AventisU.S. LLC55 CorporateDrBridgewater,NJ 08807-1265This image cannot currently be displayed.2867929, 2867930, 2883616,2883617, exp 09/2016; 2883618,2883619, 2974267, 2883620, more...DrugsAuvi-Q (epinephrine injection, USP)Auto-Injector, 0.15 mg (a) 2 prefilledauto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled autoinjector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured forSanofi-Aventis US, LLC Bridgewater,NJ 08807 A Sanofi CompanyClassIa) 2144144, exp 10/2015; 2469674,exp 04/2016; 2506492, 2546978,2546979, exp 05/2016; 2654817,2654818, exp 06/2016; 2692143,2692144, exp 07/2016; 2719838, exp08/2016; 2824845, 2891021,2857530, exp 09/2016; 2883631,2883632, exp 10/2016; 2883633,2945429, 3028243, exp 11/2016;3037230, 2966680, 2974276,2974280, exp 12/2016; and b)2525474, exp 05/2016Defective Delivery System; potential tohave inaccurate dosage deliverySanofi-AventisU.S. LLC55 CorporateDrBridgewater,NJ 08807-1265DrugsLIPO ESCULTURA capsules, 250 mg,60-count bottles, Distributed By: JATProductos Naturales Corp.,BROOKLYN, NY 11238,www.lipoesculturat reatment.comClassI All lotsMarketed Without An ApprovedNDA/ANDA: Tainted product marketedas a dietary supplement. Product foundto be tainted with sibutramine, anappetite suppressant that waswithdrawn from the U.S. market inOctober 2010 for safety reasons, anddiclofenac, a prescription non-steroidalanti-inflammatory drug, making this anunapproved drug.Lipo EsculturaCorp.888 WyckoffAveBrooklyn, NY11237-6116DrugsPink Bikini capsules, (all colors and allstrengths), packaged in 30-countbottle, Manufactured and Distributedby: Lucy's Weight Loss System (dbaWaisted With Lucy), Arlington, TX76010ClassI All lots, all colors and all strengthsMarketed without an approvedNDA/ANDA: Product containsundeclared Sibutramine,Phenolphthalein and/or Diclofenac.Lucy's WeightLoss (dba.Waisted WithLucy)813 Oram StArlington, TX76010-2837DrugsBlack Ant, packaged in Big Box (20small boxes / 4 capsules per box / 80capsules total), Distributed by: RClassI all lotsMarketed Without An ApprovedNDA/ANDAR ThomasMarketing, LLC3704 WhiteThomas Marketing, LLC, Bronx, NY10467Plains RdBronx, NY10467-5710DrugsBlack Ant, packaged in Big Box (20small boxes / 4 capsules per box / 80capsules total), Distributed by: RThomas Marketing, LLC, Bronx, NY10467ClassI all lotsMarketed Without An ApprovedNDA/ANDAR ThomasMarketing, LLC3704 WhitePlains RdBronx, NY10467-5710DrugsReal Skill, packaged in 20 small boxes/ 4 capsules per box / 80 capsulestotal, Distributed by: R ThomasMarketing, LLC, Bronx, NY 10467SHORTAGESJune 02, 2016 Lindane Lotion, USP 1% (Discontinuation)May 24, 2016 Terbinafine (Lamisil) Oral Granules (Discontinuation)May 10, 2016 Cyclosporine Capsules (Discontinuation) Imipenem and Cilastatin for Injection, USP (Discontinuation)April 26, 2016 Fluphenazine Tablets (Discontinuation)April 07, 2016 Theophylline Extended Release Tablets and Capsules (Currently in Shortage)UpdatedJune 01, 2016 Cefepime Injection (Currently in Shortage) Fentanyl Citrate (Sublimaze) Injection (Currently in Shortage) Lidocaine Hydrochloride (Xylocaine) Injection (Currently in Shortage) Multi-Vitamin Infusion (Adult and Pediatric) (Currently in Shortage) Piperacillin and Tazobactam (Zosyn) Injection (Currently in Shortage) Sodium Bicarbonate Injection, USP (Currently in Shortage) Sodium Chloride 23.4% Injection (Currently in Shortage)May 27, 2016 Tigecycline (Tygacil) Injection (Currently in Shortage)May 26, 2016 Methylprednisolone Sodium Succinate for Injection, USP (Currently in Shortage)May 25, 2016 Cefepime Injection (Currently in Shortage)May 24, 2016 Doxorubicin (Adriamycin) Injection (Currently in Shortage) Imipenem and Cilastatin for Injection, USP (Currently in Shortage) Lidocaine Hydrochloride (Xylocaine) Injection (Currently in Shortage) Methylprednisolone Sodium Succinate for Injection, USP (Currently in Shortage) Piperacillin and Tazobactam (Zosyn) Injection (Currently in Shortage) Potassium Chloride Injection (Currently in Shortage) Sodium Chloride 0.9% Injection Bags (Currently in Shortage) Sodium Chloride 23.4% Injection (Currently in Shortage) THAM Solution (Tromethamine Injection) (Discontinuation) Vancomycin Hydrochloride for Injection, USP (Currently in Shortage)HIPAA OCR Releases New HIPAA Audit Protocol and Other Audit-Related Materialso https://www.healthlawpolicymatters.com/2016/04/20/hhs-office-for-civil-rights-releases-new-hipaa-audit-protocol/PHARMACIST ED & PATIENT SAFETY Clues to How Popular Heartburn Drug Might Harm Arterieso https://www.nlm.nih.gov/medlineplus/news/fullstory_158754.html New Guidelines Recommend Prophylaxis, Antiretroviral Medications in HIV-Exposed Personso http://www.firstreportnow.com/articles/New-Guidelines-Recommend-Prophylaxis-Antiretroviral-Medications-HIV-Exposed-PersonsIMMUNIZATIONSThis image cannot currently be displayed. http://www.immunize.org/express/issue1245.asp Vaccines & Immunizationso http://www.cdc.gov/vaccines/index.htmlINSURANCE· Cortisporin Otic (May 11, 2016)· Aggrenox (May 4, 2016)· Migranal/DHE 45 (May 4, 2016)· Noxafil/Cresemba (April 13, 2016)· Nuelasta/Granix/Zarxio (March 15, 2016)· APAP/IBU/Compounded Medications (March 6, 2016)· Tetracycline/Fluoroquinolone Update (March 2, 2016)HOSPITAL Active Shooter Preparedness for Healthcare: Maturing Your Plans and Procedureso http://go.everbridge.com/active-shooter-preparedness-healthcare-maturing-your-plans-and-procedures.html?trk=FH_AS2_JUNE&mkt_tok=eyJpIjoiWmpnMU9XWXpaV013TVdJNCIsInQiOiJZRW1ZTENCMklhVk5FSWFmbXVLb010ODViM21CVmZaeFhjN3JOaW5tVUhUNHJsSVhqOFA0aXlsc3ZlVHBUR0RybzB1YW9ZYjRHY2p4byt6cEVhMWE2ZVRqWTg1MGtZZW1jSmpPaml3bzhLMD0ifQ%3D%3DFDA approval alert: Mylan launches first 200-mg Doryx generico http://www.drugstorenews.com/article/mylan-launches-first-00-mg-doryx-generic?tp=i-H55-Q5U-lm-ZSvM-1v-wGU-1c-Bi1-ZR8j-29Lz59&utm_campaign=Generics&utm_source=Experian&utm_medium=email&cid=2962&mid=8452668 FDA approves Aurobindo’s Tricor generico http://www.drugstorenews.com/article/fda-approves-aurobindos-tricor-generic?tp=i-H55-Q5U-lm-ZSvM-1v-wGU-1c-Bi3-ZR8j-dNiQq&utm_campaign=Generics&utm_source=Experian&utm_medium=email&cid=2962&mid=8452668 ISMP newso http://www.ismp.org/newsletters/acutecare/issues/20160602.pdfNEWS Do I need to worry about my teen getting hooked on Imodium?o http://www.univadis.com/viewarticle/do-i-need-to-worry-about-my-teen-getting-hooked-on-imodium-402909 Hard' Tap Water Linked to Eczema in Babieso Skin condition seems more likely in areas with high mineral content in water, study findso https://www.nlm.nih.gov/medlineplus/news/fullstory_159150.html FDA Calls for Less Salt in Processed Foodso Agency sets short- and long-term goals in effort to cut Americans' risk of high blood pressure, heart disease, strokeo https://www.nlm.nih.gov/medlineplus/news/fullstory_159136.html This content is copyright protected However, if you would like to share the information in this article, you may use the headline, summary and link below: Concealed compliance info lands ex-Ranbaxy owners $385m costs By Dan Stanton+, 10-May-2016 The former owners of Indian drugmaker Ranbaxy have been ordered to pay Daiichi Sankyo $385m for concealing quality problems across itsmanufacturing network before selling the business.http://www.in-pharmatechnologist.com/Regulatory-Safety/Concealed-compliance-info-lands-ex-Ranbaxy-owners-385m-costs

June 2016

https://dc.swosu.edu/cgi/viewcontent.cgi?article=1002&context=rural_rocks

June 2016

Abstract

Similar works

Full text

Available Versions

SWOSU Digital Commons (Southwestern Oklahoma State University)